Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report
| Autor: | T. E. Popova, Yulia Khabarova, Michil E. Andreev, T.G. Govorova, A. A. Tappakhov, Maria Yakovleva, Alina Adamova |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
neuroleptic malignant syndrome
medicine.medical_specialty parkinson’s disease General Immunology and Microbiology business.industry General Neuroscience antipsychotic drugs lcsh:R lcsh:Medicine medicine.disease Gastroenterology General Biochemistry Genetics and Molecular Biology Neuroleptic malignant syndrome Internal medicine Medicine Drug-induced parkinsonism business drug-induced parkinsonism |
| Zdroj: | International Journal of Biomedicine, Vol 10, Iss 2, Pp 174-177 (2020) |
| ISSN: | 2158-0529 2158-0510 |
| Popis: | The article presents a clinical case of neuroleptic malignant syndrome (NMS) and DIP after a single dose of thiorizadine, and discusses the issues of differential diagnosis and treatment methods. A 57-year-old patient with long-term remission of schizophrenia due to insomnia was prescribed thiorizadine. After a single dose, symptoms of parkinsonism in the form of hypokinesia, muscle rigidity and bradyphrenia developed and began to progress. Three weeks later NMS developed, and treatment was carried out in the intensive care unit. When signs of parkinsonism persisted, she was hospitalized in the neurological department. Regression of symptoms occurred by her taking amantadine sulfate. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|